Nutritional considerations after gastrectomy and esophagectomy for malignancy

Current Treatment Options in Oncology

Volumn 12, Issue 1, 2011, Pages 85-95

  Baker, Amelia ^a   Wooten, Leigh Anne ^a   Malloy, Michele ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE STIMULANT; DAI KENCHU TO; FERROUS SULFATE; GASTROINTESTINAL AGENT; GHRELIN; HEMOGLOBIN A1C; HERBACEOUS AGENT; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; OMEGA 3 FATTY ACID; PLACEBO; RIKKUNSHITO; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; CACHEXIA; CANCER SURGERY; COMPARATIVE EFFECTIVENESS; DRUG EFFECT; ENTERIC FEEDING; ESOPHAGUS RESECTION; GASTRECTOMY; HUMAN; IRON DEFICIENCY ANEMIA; LONG TERM CARE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT MONITORING; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; THERAPY EFFECT; TIME; TUBE FEEDING;

ESOPHAGECTOMY; GASTRECTOMY; HUMANS; MALNUTRITION; NEOPLASMS; PARENTERAL NUTRITION, TOTAL; POSTOPERATIVE COMPLICATIONS;

EID: 79957994090     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-010-0134-0     Document Type: Article

References (41)

1. Bower MR, Martin RC: Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol 2009, 100(1):82-87. This current literature review examines recent research surrounding the nutrition management of patients with esophageal cancer, exploring current topics in enteral and parenteral nutrition, as well as stenting.
2. August DA, Huhmann MB: American Society for Parenteral and Enteral Nutrition (A. S. P. E. N.) Board of Directors. A. S. P. E. N. clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 2009, 33(5):472-500. A widely accepted reference for clinical nutrition in regards to enteral and parenteral nutrition, these clinical guidelines are derived from a metaanalysis of nutrition support therapy during adult anticancer treatment.
3. Nitenberg G, Raynard B: Nutritional support of the cancer patient: Issues and dilemmas. Crit Rev Oncol Hematol 2000, 34(3):137-168. (Pubitemid 30320960)
4. Detsky AS, Smalley PS, Chang J: The rational clinical examination: Is this patient malnourished? JAMA 1994, 271(1):54-58.
5. Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K: Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 2002, 28(4):396-400.
6. Guo W, Ou G, Li X, Huang J, Liu J, Wei H: Screening of the nutritional risk of patients with gastric carcinoma before operation by NRS 2002 and its relationship with postoperative results. J Gastroenterol Hepatol 2010, 25(4):800-803.
7. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Ad Hoc ESPEN Working Group.: Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials. Clin Nutr 2003 22(3):321-336. (Pubitemid 36701649)
8. Demeyer I, Bataillie K, Baute L: Long-term sedation in the ICU: Enteral versus parenteral feeding. Clin Intensive Care 1994, 5 (5 Suppl): 13-16.
9. Gabor S, Renner H, Matzi V, Ratzenhofer B, Lindenmann J, Sankin O, et al.: Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr 2005, 93(4):509-513.
10. Kamei H, Hachisuka T, Nakao M, Takagi K: Quick recovery of serum diamine oxidase activity in patients undergoing total gastrectomy by oral enteral nutrition. Am J Surg 2005, 189(1):38-43. (Pubitemid 40215502)
11. Peter JV, Moran JL, Phillips-Hughes J: A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med 2005, 33(1):213-220. This metaanalysis of randomized controlled trials compares early EN with PN and shows early EN significantly reducing complication rates for patients that are treated in hospitals. (Pubitemid 40116560)
12. Lidder P, Flanagan D, Fleming S, Russell M, Morgan N, Wheatley T, et al.: Combining enteral with parenteral nutrition to improve postoperative glucose control. Br J Nutr 2010, 103(11):1635-1641.
13. Sakurai Y, Kanaya S, Komori Y, Uyama I: Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy? Esophagus 2009, 6(3):149-154.
14. Hur H, Si Y, Kang WK, Kim W, Jeon HM: Effects of early oral feeding on surgical outcomes and recovery after curative surgery for gastric cancer: Pilot study results. World J Surg 2009, 33(7):1454-1458. A clinical trial that assesses the recovery of 31 patients from a gastric resection, demonstrating early postoperative PO feeding resulting in faster recovery of bowel function and a decreased hospital LOS.
15. Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y: Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and (omega)-3 fatty acids supplemented immunonutrition. World J Surg 2009, 33(9):1815-1821.
16. Nakamura M, Iwahashi M, Takifuji K, Nakamori M, Naka T, Ishida K, et al.: Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer. Surg Today 2009, 39(10):855-860.
17. Asprer JM, Llido LO, Sinamban R, Schlotzer E, Kulkarni H: Effect on immune indices of preoperative intravenous glutamine dipeptide supplementation in malnourished abdominal surgery patients in the preoperative and postoperative periods. Nutrition 2009, 25(9):920-925.
18. Loï C, Zazzo JF, Delpierre E, Niddam C, Neveux N, Curis E, Arnaud-Battandier F, Cynober L: Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet-a pharmacokinetic randomized controlled study. Crit Care Med 2009, 37(2):501-509.
19. van Stijn MF, Boelens PG, Richir MC, Ligthart-Melis GC, Twisk JW, Diks J, et al.: Antioxidant-enriched enteral nutrition and immuno-inflammatory response after major gastrointestinal tract surgery. Br J Nutr 2010, 103(3):314-318.
20. Karcz W, Gluszek S, Kot M, Matykiewicz J: Influence of nutritional treatment on the postoperative course in patients with gastric cancer. Adv Med Sci 2006, 51:278-282.
21. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, et al.: Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: Results of a double-blinded randomized controlled trial. Ann Surg 2009, 249(3):355-363. A randomized control trial evaluating the efficacy and dosage of EPA both preoperatively and POD 21, this study found that EPA enriched EN maintained lean body mass compared to standard formula.
22. Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, et al.: Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004, 111(4):611-616. This prospective, randomized, double-blinded clinical trial compares the effects of soybean oil with a combination of fish oil and soybean oil in parenteral nutrition for gastrectomized patients. The study found that the combination of FO and SO decreased lean body mass loss, decreased ICU stay, and retained healthier liver and pancreas function. (Pubitemid 39045330)
23. Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, et al.: Effects of ghrelin administration after total gastrectomy: A prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010, 138(4):1312-1320. A prospective, randomized, placebo controlled phase II study that examines the effects of ghrelin administration after total gastrectomy, this research displays the efficacy of ghrelin, which may be more widely prescribed in the future.
24. An JY, Choi MG, Noh JH, Sohn TS, Jin DK, Kim S: Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 2007, 143(2):344-349. (Pubitemid 350101578)
25. Wang HT, Lu QC, Wang Q, Wang RC, Zhang Y, Chen HL, et al.: Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy. World J Gastroenterol 2008, 14(15):2425-2429. (Pubitemid 351877618)
26. Jeon TY, Lee S, Kim HH, Kim YJ, Lee JG, Jeong DW, et al.: Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr 2010, 64(8):826-831.
27. Yamamoto K, Takiguchi S, Miyata H, Adachi S, Hiura Y, Yamasaki M, et al.: Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery (USA) 2010, 148(1):31-38.
28. Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, Tschöp M, Kaufmann K, Holst B, Brändle M, von Moos R, Demmer R, Cerny T: Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancerrelated anorexia/cachexia: A randomised, placebocontrolled, double-blind, double-crossover study. Br J Cancer 2008, 98(2):300-308. (Pubitemid 351161246)
29. Deutsch J, Kolhouse JF: Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss. Support Care Cancer 2004, 12(7):503-510. (Pubitemid 38931683)
30. Berenstein EG, Ortiz Z: Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005, 2:004310.
31. Kang I, Kim YS, Kim C: Mineral deficiency in patients who have undergone gastrectomy. Nutrition 2007, 23:318-322. (Pubitemid 46497639)
32. Beyer PL: Medical nutrition therapy for upper gastrointestinal tract disorders. In Krause's food nutrition & diet therapy. Edited by Mahan LK, Escott-Stump S. Philadelphia: Saunders; 2004:687-702.
33. Mine S, Sano T, Tsutsumi K, Murakami Y, Ehara K, Saka M, et al.: Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg 2010, 211(5):628-636.
34. Koga M, Murai J, Saito H, Mukai M, Matsumoto S, Kasayama S: Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects. Ann Clin Biochem 2010, 47(1):39-43. This study compares the biomarkers HbA1c and GA in regards to their accuracy as a test for glycemic excursion, and finds GA to be the superior indicator.
35. Mimura EC, Breganó JW, Dichi JB, Gregório EP, Dichi I: Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients. Nutrition 2008, 24 (7-8): 663-668.
36. Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T: Effect of rikkunshito, a Chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg 2009, 33(2):296-302.
37. Endo S, Nishida T, Nishikawa K, Nakajima K, Hasegawa J, Kitagawa T, et al.: Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. Am J Surg 2006, 192(1):9-13. (Pubitemid 43870047)
38. US National Institutes of Health Clinical Trials: Oral vitamin B12 administration for vitamin B12 deficiency after total gastrectomy. http://clinicaltrials. gov/ct2/show/NCT00699478?term=00699478&rank=1. Accessed November 18, 2010.
39. US National Institutes of Health Clinical Trials: Efficacy and safety comparison between SMOFlipid and lipovenoes MCT. http://clinicaltrials.gov/ct2/ show/NCT00885781?term=NCT00885781&rank=1. Accessed November 18, 2010.
40. US National Institutes of Health Clinical Trials: The impact of low calorie and low nitrogen parenteral nutrition support on the clinical outcome of postoperative patients. http://clinicaltrials.gov/ct2/show/NCT00247338?term= NCT00247338&rank=1. Accessed November 18, 2010.
41. US National Institutes of Health Clinical Trials: Perioperative nutrition in upper gastrointestinal (GI) cancer surgery. http://clinicaltrials.gov/ct2/ show/NCT00560846?term=NCT00560846&rank=1. Accessed November 18, 2010.